Cellular Function of Phosphoinositide 3-kinases: Implications for Development, Homeostasis, and Cancer
Overview
Affiliations
The phosphoinositide 3-kinase (PI3K) family of enzymes is recruited upon growth factor receptor activation and produces 3' phosphoinositide lipids. The lipid products of PI3K act as second messengers by binding to and activating diverse cellular target proteins. These events constitute the start of a complex signaling cascade, which ultimately results in the mediation of cellular activities such as proliferation, differentiation, chemotaxis, survival, trafficking, and glucose homeostasis. Therefore, PI3Ks play a central role in many cellular functions. The factors that determine which cellular function is mediated are complex and may be partly attributed to the diversity that exists at each level of the PI3K signaling cascade, such as the type of stimulus, the isoform of PI3K, or the nature of the second messenger lipids. Numerous studies have helped to elucidate some of the key factors that determine cell fate in the context of PI3K signaling. For example, the past two years has seen the publication of many transgenic and knockout mouse studies where either PI3K or its signaling components are deregulated. These models have helped to build a picture of the role of PI3K in physiology and indeed there have been a number of surprises. This review uses such models as a framework to build a profile of PI3K function within both the cell and the organism and focuses, in particular, on the role of PI3K in cell regulation, immunity, and development. The evidence for the role of deregulated PI3K signaling in diseases such as cancer and diabetes is reviewed.
Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).
PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.
The Role and Mechanism of TRIM Proteins in Gastric Cancer.
Wu W, Yang J, Yu T, Zou Z, Huang X Cells. 2025; 13(24.
PMID: 39768197 PMC: 11674240. DOI: 10.3390/cells13242107.
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy.
Han B, Lin X, Hu H Transl Breast Cancer Res. 2024; 5:33.
PMID: 39534586 PMC: 11557167. DOI: 10.21037/tbcr-24-29.
Huang D, Yang J, Zhang Q, Zhou X, Wang Y, Shang Z Front Pharmacol. 2024; 15:1467028.
PMID: 39498341 PMC: 11533140. DOI: 10.3389/fphar.2024.1467028.
The PIK3CA gene and its pivotal role in tumor tropism of triple-negative breast cancer.
Mallick S, Duttaroy A, Dutta S Transl Oncol. 2024; 50:102140.
PMID: 39369580 PMC: 11491976. DOI: 10.1016/j.tranon.2024.102140.